Intra-Cellular Therapies ITCI 深 滬
等待開盤 09-20 09:30:00 美东时间
76.97
+2.270
+3.04%
華盛通- 最 高77.18
- 今 開75.12
- 成交量 54.71万股
- 最 低 74.615
- 昨 收 74.70
- 總市值 74.51亿
- 52周最高 84.89
- 市盈率 靜 --
- 換手率 0.57%
- 52周最低 45.50
- 委 比 -74.28%
- 總股本 9680.72万
- 歷史最高 84.89
- 量 比 1.28
- 振 幅 3.43%
- 歷史最低 6.75
- 每 手 1
- 風險率 7.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cantor Fitzgerald Reiterates Overweight on Intra-Cellular Therapies, Maintains $130 Price Target
Cantor Fitzgerald analyst Charles Duncan reiterates Intra-Cellular Therapies (NASDAQ:ITCI) with a Overweight and maintains $130 price target.
09-16 23:50
Stock moves reflect downgrade for US economic growth outlook - Goldman
Equity rotations recently are reflecting a downgrade for the growth outlook on the US economy, but the S&P 500 (SP500) remains near its all-time high because of anticipated interest-rate cuts by the F...
09-16 03:48
Piper Sandler ups Intra-Cellular to overweight, cites Caplyta potential
Piper Sandler upgraded Intra-Cellular Therapies (NASDAQ:ITCI) to overweight, citing Caplyta’s sales potential. The investment bank said its survey of 25 psychiatrists indicated that the patient/prescr...
09-07 06:01
Expert Ratings For Intra-Cellular Therapies
In the latest quarter, 16 analysts provided ratings for Intra-Cellular Therapie...
09-07 02:00
快讯 | Intra-Cellular Therapies Inc ：JP Morgan 将目标价从$79 上调至$81
Intra-Cellular Therapies Inc : JP Morgan Raises Target Price to $81 From $79
08-21 12:21
快讯 | Intra-Cellular Therapies公司：派杰投资将目标价从65美元上调至68美元。
Intra-Cellular Therapies Inc : Piper Sandler Raises Target Price to $68 From $65
08-08 15:58
Intra-Cellular Therapies Financial Outlook: Cautious Amid Expansion and Pipeline Progress
Goldman Sachs analyst Corinne Johnson reiterated a Hold rating on Intra-Cellula...
08-08 02:55
Deep Dive Into Intra-Cellular Therapies Stock: Analyst Perspectives (9 Ratings)
9 analysts have shared their evaluations of Intra-Cellular Therapies (NASDAQ:IT...
08-07 21:01
Intra-Cellular Therapies names Sanjeev Narula as CFO
Intra-Cellular Therapies (NASDAQ:ITCI) said it has appointed Sanjeev Narula as CFO, and executive vice president. Narula will join the company on August 12. Current finance chief, Lawrence Hineline wi...
08-07 19:59
快讯 | intra-cellular therapies宣布任命Sanjeev Narula为致富金融(临时代码)官员
Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Finan...
08-07 19:41
